PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
18-Apr-2024 Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity Biophytis
18-Apr-2024 Sartorius Stedim Biotech publishes unaudited first quarter results for 2024 Sartorius Stedim Biotech SA
18-Apr-2024 DocMorris successfully completes the placement of CHF 200 million Convertible Bonds due 2029 DocMorris AG
17-Apr-2024 Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon Lonza Group AG
17-Apr-2024 aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages aap Implantate AG
17-Apr-2024 DocMorris launches approx. CHF 200 million Convertible Bonds due 2029 DocMorris AG
17-Apr-2024 Evotec SE to announce results for fiscal year 2023 on 24 April 2024 Evotec SE
17-Apr-2024 Annual General Meeting of Kuros Biosciences approves all resolutions Kuros Biosciences AG
17-Apr-2024 DEFENCE THERAPEUTICS SIGNS WITH GERMAN BASED FMS CONSULT GMBH FOR FINANCING STRATEGY TO SUPPORT DEFENCE PIPELINE GROWTH Defence Therapeutics Inc.
17-Apr-2024 Evotec welcomes Aurélie Dalbiez as Chief People Officer Evotec SE
17-Apr-2024 Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera Spexis AG
17-Apr-2024 Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination with Curatis AG and Reverse Share Split Kinarus Therapeutics Holding AG
16-Apr-2024 CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines CureVac
16-Apr-2024 BRAIN Biotech AG takes next step to optimize group structure BRAIN Biotech AG
16-Apr-2024 ELRIG UK and SRG Announce Partnership to Advance Life Science Professionals in Drug Discovery ELRIG UK and SRG
16-Apr-2024 Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets Marinomed Biotech AG
16-Apr-2024 PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024 PharmaSGP Holding SE
16-Apr-2024 DocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market DocMorris AG
15-Apr-2024 Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed Drägerwerk AG & Co. KGaA
15-Apr-2024 Strong financial foundation: DOUGLAS Group reduces net debt by 1 billion euros and increases financial flexibility Douglas AG